PL2519527T3 - Tieno[2,3-B]Pirydynodionowe aktywatory AMPK i ich zastosowanie terapeutyczne - Google Patents

Tieno[2,3-B]Pirydynodionowe aktywatory AMPK i ich zastosowanie terapeutyczne

Info

Publication number
PL2519527T3
PL2519527T3 PL10800766T PL10800766T PL2519527T3 PL 2519527 T3 PL2519527 T3 PL 2519527T3 PL 10800766 T PL10800766 T PL 10800766T PL 10800766 T PL10800766 T PL 10800766T PL 2519527 T3 PL2519527 T3 PL 2519527T3
Authority
PL
Poland
Prior art keywords
pyridinedione
ampk
thieno
activators
therapeutic uses
Prior art date
Application number
PL10800766T
Other languages
English (en)
Inventor
Daniel Cravo
Sophie Hallakou-Bozec
Sébastien Bolze
Franck Lepifre
Laurent Faveriel
Jean-Denis Durand
Christine Charon
Original Assignee
Poxel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poxel filed Critical Poxel
Publication of PL2519527T3 publication Critical patent/PL2519527T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL10800766T 2009-12-29 2010-12-28 Tieno[2,3-B]Pirydynodionowe aktywatory AMPK i ich zastosowanie terapeutyczne PL2519527T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09306344 2009-12-29
PCT/EP2010/070811 WO2011080277A1 (en) 2009-12-29 2010-12-28 Thieno [2,3-b] pyridinedione activators of ampk and therapeutic uses thereof
EP10800766.7A EP2519527B1 (en) 2009-12-29 2010-12-28 Thieno[2,3-b]pyridinedione activators of ampk and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
PL2519527T3 true PL2519527T3 (pl) 2014-06-30

Family

ID=41691577

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10800766T PL2519527T3 (pl) 2009-12-29 2010-12-28 Tieno[2,3-B]Pirydynodionowe aktywatory AMPK i ich zastosowanie terapeutyczne

Country Status (24)

Country Link
US (1) US9365584B2 (pl)
EP (1) EP2519527B1 (pl)
JP (1) JP5559894B2 (pl)
KR (1) KR101469002B1 (pl)
CN (1) CN102803269B (pl)
AU (1) AU2010338280B2 (pl)
BR (1) BR112012016330B8 (pl)
CA (1) CA2784553C (pl)
CY (1) CY1114952T1 (pl)
DK (1) DK2519527T3 (pl)
EA (1) EA020588B1 (pl)
ES (1) ES2445537T3 (pl)
HR (1) HRP20140035T1 (pl)
IL (1) IL220432A (pl)
ME (1) ME01558B (pl)
MX (1) MX2012007548A (pl)
PL (1) PL2519527T3 (pl)
PT (1) PT2519527E (pl)
RS (1) RS53282B (pl)
SI (1) SI2519527T1 (pl)
SM (1) SMT201400013B (pl)
TW (1) TWI574968B (pl)
WO (1) WO2011080277A1 (pl)
ZA (1) ZA201205604B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3329919T (lt) 2011-11-11 2020-02-10 Gilead Apollo, Llc Acc inhibitoriai ir jų panaudojimas
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
CA2905242C (en) 2013-03-15 2016-11-29 Pfizer Inc. Indole compounds that activate ampk
US10143703B2 (en) 2014-01-02 2018-12-04 Massachusetts Eye And Ear Infirmary Treating ocular neovascularization
WO2017011917A1 (en) * 2015-07-23 2017-01-26 Thrasos Therapeutics Inc. Methods for treating and preventing polycystic kidney diseases (pkd) using amp-activated protein kinase (ampk) modulators and activators
AR106472A1 (es) 2015-10-26 2018-01-17 Gilead Apollo Llc Inhibidores de acc y usos de los mismos
PT3380480T (pt) 2015-11-25 2023-03-14 Gilead Apollo Llc Inibidores de pirazol acc e seus usos
MX2018006288A (es) 2015-11-25 2018-09-07 Gilead Apollo Llc Inhibidores de acc tipo ester y usos de los mismos.
BR112018009212B1 (pt) 2015-11-25 2022-06-14 Gilead Apollo, Llc Método para controlar patógenos fúngicos agrícolas
MX2018006287A (es) 2015-11-25 2018-09-07 Gilead Apollo Llc Inhibidores de acc de triazol y usos de los mismos.
KR102622161B1 (ko) 2016-03-02 2024-01-09 길리어드 아폴로, 엘엘씨 티에노피리미딘디온 acc 억제제의 고체 형태 및 그의 제조 방법
US10793527B2 (en) 2016-09-07 2020-10-06 National Yang-Ming University Adenosine monophosphate-activated protein kinase agonist
JP6906626B2 (ja) 2017-03-28 2021-07-21 ギリアード サイエンシーズ， インコーポレイテッド 肝疾患を処置するための治療的組み合わせ
WO2019185413A1 (en) 2018-03-27 2019-10-03 Basf Se Pesticidal substituted cyclopropyl derivatives
MX2022014505A (es) 2020-05-19 2022-12-13 Kallyope Inc Activadores de la ampk.
EP4172162A1 (en) 2020-06-26 2023-05-03 Kallyope, Inc. Ampk activators
CN116322663A (zh) 2020-09-30 2023-06-23 比奥维拉迪维治疗股份有限公司 Ampk激活剂及其使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119205B2 (en) * 2003-05-16 2006-10-10 Abbott Laboratories Thienopyridones as AMPK activators for the treatment of diabetes and obesity
PT2262500T (pt) 2008-04-11 2016-08-16 Merck Patent Gmbh Derivados de tienopiridona como ativadores da proteína quinase ativada por amp (ampk)

Also Published As

Publication number Publication date
PT2519527E (pt) 2014-02-17
JP5559894B2 (ja) 2014-07-23
SI2519527T1 (sl) 2014-06-30
CN102803269B (zh) 2016-01-13
CA2784553C (en) 2014-08-19
AU2010338280A1 (en) 2012-07-26
BR112012016330A2 (pt) 2018-04-03
RS53282B (en) 2014-08-29
TW201144318A (en) 2011-12-16
EA020588B1 (ru) 2014-12-30
EA201200975A1 (ru) 2012-12-28
ES2445537T3 (es) 2014-03-03
CA2784553A1 (en) 2011-07-07
HRP20140035T1 (hr) 2014-02-14
CY1114952T1 (el) 2016-12-14
KR101469002B1 (ko) 2014-12-04
EP2519527A1 (en) 2012-11-07
TWI574968B (zh) 2017-03-21
MX2012007548A (es) 2012-07-23
AU2010338280B2 (en) 2013-08-22
EP2519527B1 (en) 2013-12-18
BR112012016330B1 (pt) 2021-03-23
ME01558B (me) 2014-04-20
BR112012016330B8 (pt) 2021-05-25
WO2011080277A1 (en) 2011-07-07
IL220432A (en) 2015-02-26
DK2519527T3 (da) 2014-01-27
KR20120120232A (ko) 2012-11-01
JP2013515758A (ja) 2013-05-09
SMT201400013B (it) 2014-05-07
US9365584B2 (en) 2016-06-14
CN102803269A (zh) 2012-11-28
US20130053401A1 (en) 2013-02-28
ZA201205604B (en) 2013-05-29

Similar Documents

Publication Publication Date Title
PL2519527T3 (pl) Tieno[2,3-B]Pirydynodionowe aktywatory AMPK i ich zastosowanie terapeutyczne
HK1253364A1 (zh) 1h-吡唑並[3，4-b]吡啶及其治療應用
EP2424366A4 (en) PYRIDO [4.3-B] INDOLES AND THEIR METHODS OF USE
EP2424364A4 (en) PYRIDO [4.3-B] INDOLES AND METHODS OF USE
EP2480078A4 (en) PYRIDO- [4,3-B] INDOLE AND USE METHOD THEREFOR
EP2480080A4 (en) PYRIDO [3,4-B] INDOLES AND METHODS OF USE
IL216609A0 (en) Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives
IL219424A0 (en) IMIDAZO [1,2-b] PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
EP2244708A4 (en) NOVEL 2,3,4,5-TETRAHYDRO-1H-PYRIDO [4,3-B] INDOLE COMPOUNDS AND METHODS OF USE
IL215286A0 (en) 9h-pyrrolo[2,3-b:5,4-c]dipridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
HK1163679A1 (en) Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof 2--2---3(2h)-
IL215103A0 (en) N-[(6-AZA-bicyclo[3.2.1]OCT-5-YL]-ARYL-METHYL]-HETEROBENZAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE OF SAME
IL220448A0 (en) Substituted pyrido [2,3-d] pyrimidin - 7h (8h)-ones and therapeutic uses thereof
ZA201104783B (en) Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one,preparation and therapeutic use thereof as hif activators
EP2603512A4 (en) DERIVATIVES OF 6,7-DIHYDRO-3H-OXAZOLO- [3,4-A] PYRAZIN-5,8-DION
IL215733A0 (en) 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof
IL246841A0 (en) Bicyclic derivatives [2,2,2] and methods of use